Ofloxacin Tablets

Published Online: Monday, March 1, 2004

Teva Pharmaceuticals USA (North Wales, Pa) recently announced the introduction and availability of Ofloxacin Tablets. This product is AB-rated and is bioequivalent to Ortho-McNeil?s Floxin tablets. The product is prescribed to patients to reduce the development of drug-resistant bacteria and to maintain the effectiveness of this and other antibacterial drugs. Ofloxacin Tablets are indicated for the treatment of adults with mild-to-moderate infections (unless otherwise indicated) caused by susceptible strains of designated microorganisms. These infections include chronic bronchitis, community-acquired pneumonia, and acute pelvic inflammatory disease, among others. Ofloxacin Tablets 200, 300, and 400 mg are available in bottle sizes of 100. For more information, visit www.tevapharmusa.com.



Related Articles
No Result Found
Latest Issues
$auto_registration$